Decibel Cannabis Co Inc is engaged in the cannabis operations business... Show more
The Stochastic Oscillator for DBCCF moved into oversold territory on December 24, 2025. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where DBCCF's RSI Oscillator exited the oversold zone, of 16 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .
The Moving Average Convergence Divergence (MACD) for DBCCF just turned positive on December 11, 2025. Looking at past instances where DBCCF's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where DBCCF advanced for three days, in of 246 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on December 24, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DBCCF as a result. In of 130 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
DBCCF moved below its 50-day moving average on November 18, 2025 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for DBCCF crossed bearishly below the 50-day moving average on November 18, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 12 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where DBCCF declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
DBCCF broke above its upper Bollinger Band on December 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for DBCCF entered a downward trend on December 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.956) is normal, around the industry mean (24.311). P/E Ratio (3.513) is within average values for comparable stocks, (74.353). DBCCF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.954). DBCCF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.534) is also within normal values, averaging (64.216).
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. DBCCF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. DBCCF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry PharmaceuticalsGeneric